Matrixx Sales Drop Nearly 30% In Final Quarter Before Buyout
This article was originally published in The Tan Sheet
Matrixx Initiatives posts an $11.3 million net loss in what is likely its last quarter as a publicly traded company before its acquisition by private equity firm H.I.G. Capital.
You may also be interested in...
In litigation between Matrixx Initiatives and shareholders, the Supreme Court appears concerned with striking a balance between requiring the disclosure of any facts that could affect investors' decisions and the release of so much information that important facts are obscured.
Matrixx Initiatives announced Dec. 14 private equity firm H.I.G. Capital will acquire the Scottsdale, Ariz.-based maker of Zicam cough/cold products for approximately $75.2 million.
Matrixx Initiatives anticipates retailers' orders to increase during the cold and flu season across the firm's upcoming quarters after sales fell 15.7% in its latest quarter.